Summary Information:
Biotech Acquisition Company Unit
NASDAQ:BIOTU


email
admin@troach.net
Our Main Pages
Stocks.TRoach.Net
TRoach.Org
TRoach.Net

NOTE: This page is for evaluation of a JFF Project.
This page is NOT updated on a regular basis.
Information on this page should NOT be used for investment purposes.


Biotech Acquisition Company Unit
Exchange: NASDAQ
Symbol: BIOTU
SEC CIK: 0001825413
Phone: 8586920539
545 WEST 25TH STREET
20TH FLOOR
NEW YORK NY 10001
CEO:
Price when page updated: 10.13 Date: 2022-12-26
Company Website:

_Description: Biotech Acquisition Company, a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or other similar business combination with one or more businesses. Although the Company may pursue a business target in any industry or geographic location, the Company intends to focus its search for a target business in the healthcare sector. The Company believes that this focus will complement its sponsor’s and management team’s background as affiliates of SPRIM Global Investments, a leading life science investment firm in the healthcare industry. The Company expects that its target sector will have a particular focus on life sciences/ biotechnology, healthcare information technology, medical technology and technology-enabled healthcare service sectors.

IPO YEAR:
2021
Sector:
Finance
Industry:
Business Services
ADRTSO:

MarketCap:
0.00
Beta:

52 Week High:
10.95
52 Week Low:
9.3
52 Week Change:
-0.02133850630455869
Short Interest:

Short Date:

Shares Outstanding:
23000000
Dividend Rate:
0
Dividend Yield:
0.00%
ExDividend Date:

Latest EPS:

Latest EPS Date:
14 Nov 2022
Float:
0
return on Equity:
-
Consensus EPS:

Number Of Estimates:

EPS Surprise Dollar:

Eps Surprise Percent:

EBITDA:
N/A
ttmEPS:
0
Revenue:
$423.264M
Gross Profit:

Cash:

Debt:

Institution Percent:
48.50%
Revenue Percent:

Revenue Per Employee:

Insider Percent:
0.70%
Return on Assets:
-
Return on Capital:

Profit Margin:
-
Price to Sales:
-
Price To Book:
2.74
Short Ratio:
3.96
PE Ratio:
0
Employees:
4
1Y Guesstimate
N/A:N/A:N/A




__The following are links to various summary and news pages for
__Biotech Acquisition Company Unit [ BIOTU ].

__Note: Some Links might not have information for the company.


finance.Yahoo.com money.CNN.com NASDAQ research
WalletInvestor.com WSJ.com MarketBeat.com
finviz.com WallMine.com TheGlobeandMail.com
stock1010.com
NASDAQ - General Info SEC Insider Report Ownership Summary
Dividend History insiderbuyingselling.com
Facebook search Twitter search LinkedIn search
PRnewsWire.Com Google Forecast
tdameritrade.com BarChart.com
SeekingAlpha.com Markets.FT.com stocktwits.com
FinTel.io Ldmicro.com bloomberg.com
MarketWatch.com Reuters.com businessinsider.com
fool.com barrons.com zacks.com
GuruFocus.com Investing.com tipranks.com
thestreet.com nytimes.com earningswhispers.com
marketchameleon.com sunshineavenue.com stockinvest.us
stockanalysis.com stockconsultant.com ycharts.com
financialcontent.com docoh.com foxbusiness.com
cnbc.com investorsobserver.com tradingview.com
investopedia.com tmxmoney.com invest.cnyes.com
ask.com bing.com brave.com
duckduckgo.com ecosia.org excite.com
exalead.com gibiru.com hotbot.com
www.info.com infospace.com lycos.com
lukol.com metacrawler.com mojeek.com
becovi.com searx.thegpm.org search.com
swisscows.com webcrawler.com yahoo.com
yandex.com yep.com you.com




INDEX




Page design by: TRoach
Page Last Updated: 2022-12-26